{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:01:23Z","timestamp":1790125283192,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.intimp.2024.112696","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T21:48:52Z","timestamp":1721166532000},"page":"112696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Neogambogic acid enhances anti-PD-1 immunotherapy efficacy by attenuating suppressive function of MDSCs in pancreatic cancer"],"prefix":"10.1016","volume":"139","author":[{"given":"Jing","family":"Xun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7575-3939","authenticated-orcid":false,"given":"Xiaolin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingdi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112696_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102016","article-title":"Immunotherapy for pancreatic cancer: A 2020 update","volume":"86","author":"Schizas","year":"2020","journal-title":"Cancer Treat Rev."},{"issue":"1","key":"10.1016\/j.intimp.2024.112696_b0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41571-018-0112-1","article-title":"Optimizing the outcomes of pancreatic cancer surgery","volume":"16","author":"Strobel","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112696_b0015","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","article-title":"Challenges and Opportunities for Pancreatic Cancer Immunotherapy","volume":"38","author":"Bear","year":"2020","journal-title":"Cancer Cell."},{"key":"10.1016\/j.intimp.2024.112696_b0020","doi-asserted-by":"crossref","unstructured":"Grunwald, B.T., A. Devisme, G. Andrieux, F. Vyas, K. Aliar, C.W. McCloskey, et al., Spatially confined sub-tumor microenvironments in pancreatic cancer. Cell. 184 (22) (2021) 5577-5592 e18, 10.1016\/j.cell.2021.09.022.","DOI":"10.1016\/j.cell.2021.09.022"},{"issue":"2","key":"10.1016\/j.intimp.2024.112696_b0025","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112696_b0030","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/cgt.2016.65","article-title":"Myeloid-derived suppressor cells and their role in pancreatic cancer","volume":"24","author":"Pergamo","year":"2017","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.intimp.2024.112696_b0035","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3389\/fimmu.2020.00783","article-title":"Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors","volume":"11","author":"Hou","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.intimp.2024.112696_b0040","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jconrel.2022.09.010","article-title":"Local delivery of gambogic acid to improve anti-tumor immunity against oral squamous cell carcinoma","volume":"351","author":"Chen","year":"2022","journal-title":"J Control Release."},{"issue":"1","key":"10.1016\/j.intimp.2024.112696_b0045","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s40425-019-0817-4","article-title":"Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth","volume":"7","author":"Cao","year":"2019","journal-title":"J Immunother Cancer."},{"key":"10.1016\/j.intimp.2024.112696_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114370","article-title":"Development of natural products for anti-PD-1\/PD-L1 immunotherapy against cancer","volume":"281","author":"Ri","year":"2021","journal-title":"J Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112696_b0055","first-page":"197","article-title":"Neogambogic acid induces apoptosis of melanoma B16 cells via the PI3K\/Akt\/mTOR signaling pathway","volume":"67","author":"Wu","year":"2020","journal-title":"Acta Biochim Pol."},{"key":"10.1016\/j.intimp.2024.112696_b0060","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.2147\/IJN.S82980","article-title":"Enhancement of radiotherapy by ceria nanoparticles modified with neogambogic acid in breast cancer cells","volume":"10","author":"Chen","year":"2015","journal-title":"Int J Nanomedicine."},{"issue":"1","key":"10.1016\/j.intimp.2024.112696_b0065","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ptr.7614","article-title":"Gambogenic acid induces apoptosis and autophagy through ROS-mediated endoplasmic reticulum stress via JNK pathway in prostate cancer cells","volume":"37","author":"Wu","year":"2023","journal-title":"Phytother Res."},{"key":"10.1016\/j.intimp.2024.112696_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115110","article-title":"Gambogenic acid induces ferroptosis in melanoma cells undergoing epithelial-to-mesenchymal transition","volume":"401","author":"Wang","year":"2020","journal-title":"Toxicol Appl Pharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2024.112696_b0075","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.intimp.2008.05.013","article-title":"Gambogic acid induced tumor cell apoptosis by T lymphocyte activation in H22 transplanted mice","volume":"8","author":"Gu","year":"2008","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.112696_b0080","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.2147\/IJN.S408521","article-title":"Cancer Cell Membrane-Coated Gambogic Acid Nanoparticles for Effective Anticancer Vaccination by Activating Dendritic Cells","volume":"18","author":"Huang","year":"2023","journal-title":"Int J Nanomedicine."},{"key":"10.1016\/j.intimp.2024.112696_b0085","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.12659\/MSM.909651","article-title":"Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor kappaB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-kappaB Pathways in Mouse Bone Marrow-Derived Monocyte\/Macrophages","volume":"24","author":"Jin","year":"2018","journal-title":"Med Sci Monit."},{"key":"10.1016\/j.intimp.2024.112696_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109839","article-title":"Dioscin modulates macrophages polarization and MDSCs differentiation to inhibit tumorigenesis of colitis-associated colorectal cancer","volume":"117","author":"Xun","year":"2023","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.112696_b0095","article-title":"Hydroxytyrosol Inhibits MDSCs and Promotes M1 Macrophages in Mice With Orthotopic Pancreatic Tumor","volume":"12","author":"Wang","year":"2021","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.intimp.2024.112696_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153306","article-title":"Gambogenic acid induces Noxa-mediated apoptosis in colorectal cancer through ROS-dependent activation of IRE1alpha\/JNK","volume":"78","author":"Zhao","year":"2020","journal-title":"Phytomedicine."},{"issue":"3","key":"10.1016\/j.intimp.2024.112696_b0105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41419-019-1360-4","article-title":"Gambogic acid triggers vacuolization-associated cell death in cancer cells via disruption of thiol proteostasis","volume":"10","author":"Seo","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2024.112696_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113636","article-title":"Gambogenic acid antagonizes the expression and effects of long non-coding RNA NEAT1 and triggers autophagy and ferroptosis in melanoma","volume":"154","author":"Wang","year":"2022","journal-title":"Biomed Pharmacother."},{"issue":"10","key":"10.1016\/j.intimp.2024.112696_b0115","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1248\/bpb.b23-00156","article-title":"Gambogenic Acid Inhibits Invasion and Metastasis of Melanoma through Regulation of lncRNA MEG3","volume":"46","author":"Wang","year":"2023","journal-title":"Biol Pharm Bull."},{"issue":"1","key":"10.1016\/j.intimp.2024.112696_b0120","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12943-022-01657-y","article-title":"Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy","volume":"21","author":"Wu","year":"2022","journal-title":"Mol Cancer."},{"issue":"26","key":"10.1016\/j.intimp.2024.112696_b0125","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N Engl J Med."},{"key":"10.1016\/j.intimp.2024.112696_b0130","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.canlet.2019.10.015","article-title":"Targeting USP9x\/SOX2 axis contributes to the anti-osteosarcoma effect of neogambogic acid","volume":"469","author":"Chen","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2024.112696_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175112","article-title":"Neogambogic acid suppresses characteristics and growth of colorectal cancer stem cells by inhibition of DLK1 and Wnt\/beta-catenin pathway","volume":"929","author":"Li","year":"2022","journal-title":"Eur J Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112696_b0140","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.etap.2011.12.006","article-title":"Gambogenic acid induced mitochondrial-dependent apoptosis and referred to phospho-Erk1\/2 and phospho-p38 MAPK in human hepatoma HepG2 cells","volume":"33","author":"Yan","year":"2012","journal-title":"Environ Toxicol Pharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2024.112696_b0145","first-page":"641","article-title":"Anticancer activity and underlying mechanism of neogambogic acid","volume":"16","author":"Sun","year":"2018","journal-title":"Chin J Nat Med."},{"issue":"6","key":"10.1016\/j.intimp.2024.112696_b0150","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4196\/kjpp.2022.26.6.511","article-title":"Neogambogic acid relieves myocardial injury induced by sepsis via p38 MAPK\/NF-kappaB pathway","volume":"26","author":"Fu","year":"2022","journal-title":"Korean J Physiol Pharmacol."},{"key":"10.1016\/j.intimp.2024.112696_b0155","doi-asserted-by":"crossref","first-page":"1045291","DOI":"10.3389\/fmicb.2022.1045291","article-title":"Investigations into the antibacterial effects and potential mechanism of gambogic acid and neogambogic acid","volume":"13","author":"Li","year":"2022","journal-title":"Front Microbiol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112696_b0160","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41568-022-00546-2","article-title":"Therapeutic targeting of tumour myeloid cells","volume":"23","author":"Barry","year":"2023","journal-title":"Nat Rev Cancer."},{"issue":"5","key":"10.1016\/j.intimp.2024.112696_b0165","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.trecan.2023.01.007","article-title":"From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts","volume":"9","author":"Arpinati","year":"2023","journal-title":"Trends Cancer."},{"key":"10.1016\/j.intimp.2024.112696_b0170","doi-asserted-by":"crossref","unstructured":"Chen, Y., J. Kim, S. Yang, H. Wang, C.J. Wu, H. Sugimoto, et al., Type I collagen deletion in alphaSMA(+) myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer. Cancer Cell. 39 (4) (2021) 548-565 e6, 10.1016\/j.ccell.2021.02.007.","DOI":"10.1016\/j.ccell.2021.02.007"},{"issue":"1","key":"10.1016\/j.intimp.2024.112696_b0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41421-023-00529-z","article-title":"CD36(+) cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor","volume":"9","author":"Zhu","year":"2023","journal-title":"Cell Discov."},{"issue":"1","key":"10.1016\/j.intimp.2024.112696_b0180","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/s41467-018-03347-0","article-title":"Cancer-associated fibroblasts induce antigen-specific deletion of CD8 (+) T Cells to protect tumour cells","volume":"9","author":"Lakins","year":"2018","journal-title":"Nat Commun."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924012177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924012177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T07:22:50Z","timestamp":1732951370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924012177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":36,"alternative-id":["S1567576924012177"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112696","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neogambogic acid enhances anti-PD-1 immunotherapy efficacy by attenuating suppressive function of MDSCs in pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112696","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112696"}}